hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 17:30:01 - browse：781

Ula Jurkunas, associate director of the cornea service at Mass Eye and Ear, performs the first CALEC surgery. Courtesy Mass Eye and Ear

The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.”

A year earlier, in April 2017, Durst had lost sight from that same eye after it was hit by a caustic water treatment solution in a work accident. The damage was so severe that a standard corneal transplant would not resolve it. But in April 2018, he underwent a new, innovative procedure: An eye stem cell transplant led by Ula Jurkunas, the associate director of the cornea service at Mass Eye and Ear in Boston.

Durst, now 51 years old, is the first of four patients who were included in a Phase 1 trial of Cultivated Autologous Limbal Epithelial Cell (CALEC) transplant, the results of which were published Friday in Science Advances. The procedure allowed him to become a suitable candidate for another surgery, the artificial corneal transplant, while rehabilitating his vision — and his life.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

WSS

Vertex non

Some dementia cases could be undiagnosed liver disease

Police still searching for prisoner who escaped from NYC hospital

Biden administration opens offers in Medicare drug price negotiations

Methadone doses haven’t kept up in the age of fentanyl

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

knowledge

hotspot

explore

Wildfire smoke exposes gaps in outdoor worker protections

Why failed clinical trials don’t always spell doom for a new drug

Walensky prepares to leave CDC — and Congress — behind

Apple Vision Pro: A first look at health apps on the new VR headset

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ARCH Venture Partners is raising $3 billion for a life sciences fund

Trump demands the U.S. pay no more for drugs than other countries … again

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

After affirmative action ruling, medical educators look to 'holistic review'

The lessons of Aduhelm, an Alzheimer's drug that was not to be

hotspot

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

NIH trials fail to test meaningful long Covid therapies, experts say

New Ultima Genomics DNA sequencer can read genome for $100

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Novo Nordisk to expand supply of Wegovy for U.S. patients

hotspot

explore

entertainment

leisure time